Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Elspeth Garman (l) in conversation with Emeritus Professor Edith Sim at this week's Paton Prize presentation

The Department of Pharmacology offers its congratulations to Professor Elspeth Garman who has been awarded the Eleventh Max Perutz Prize by the European Crystallographic Association (ECA).

Professor Garman is a member of the Department of Biochemistry but serves on the Strategic Advisory Board for the Department of Pharmacology. She was an adjudicator for this week's Paton Prize for our second year DPhil students.

The Max Perutz Prize is awarded in recognition of Elspeth Garman’s invaluable contribution to the field of macromolecular crystallographic methods by developing tools and methods for improving the quality of diffraction data.

Elspeth Garman’s science has also been much involved in the elucidation of many important biological structures, among others, the structures of neuraminidases linked to pandemic influenza viruses and bacteria.

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.